About: Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.43 (+9.73%)
NERV NASDAQ Minerva Neurosciences Inc
Minerva Neurosciences Inc share price
Atividade de preço de NERV
Último preço
$ 2,430
Variação (24h)
0,22 USD (9,73%)
Volume
97.69K
Volume (média 4 sem.)
-
Abertura
$ 2,25
Variação do dia
$ 2,21 - $ 2,43
Fechamento anterior
$ 2,21
Último negócio
29 Oct, 3:05 pm GMT+0
Atrasado
29 Oct, 3:05 pm GMT+0
NERV price performance
Atrasado
29 Oct, 3:05 pm GMT+0
quote.marketSignals